Liverpool have consistently led by example in recent transfer windows, even if they’ve sometimes been criticised for not splashing cash like Manchester City.
That narrative may be shifting now, especially with the Reds’ ambitious pursuit of Bayer Leverkusen star Florian Wirtz. This move could see them smash their transfer record, proving they’re willing to spend big when the right opportunity arises.
Still, this doesn’t mark a departure from Liverpool’s long-standing focus on sustainability. Under new boss Arne Slot, the club will likely need to sell players before making further major signings.
Saudi Pro League Eyes Darwin Nunez
It’s no shock that Darwin Nunez is attracting serious interest from Saudi Arabia. At 25, he fits the league’s new strategy of targeting players at or entering their peak years, moving away from an aging star model.
Why Selling Nunez Could Work for Liverpool
Darwin Nunez’s time at Liverpool has had its thrilling moments. His chaotic, high-energy style brought a unique flavor during Jurgen Klopp’s final seasons.
However, Slot’s more technical and structured system has exposed some of Nunez’s limitations. Most notably, he’s been criticised for his inconsistency in front of goal and perceived lack of intensity off the ball.
In the 2024/25 season, the Uruguayan striker managed just five Premier League goals, with a total of 14 goal contributions across all competitions in 1,118 minutes. That scoring output simply doesn’t meet the standard expected of a Liverpool No.9.
To put it in perspective, Nunez scores a Premier League goal every 223.6 minutes—lagging well behind forwards like Matheus Cunha (173), Luis Diaz (185), and even Cody Gakpo (194).
Mo Salah’s Influence and the Harsh Reality
While Nunez’s struggles can partly be explained by Liverpool’s attacking setup—which is clearly tailored to get Mohamed Salah into scoring positions—this excuse wears thin for a striker entering his third season at the club.
Nobody expects him to match Salah’s incredible numbers, but Liverpool need a more reliable and clinical presence up front
